Key result
Misinterpreting pulmonary lymphangitic carcinomatosis as sarcoidosis leads to inappropriate nephrectomy and death in RCC.
Why the study?
Pulmonary lymphangitic carcinomatosis is a rare manifestation of renal cell carcinoma that can mimic benign interstitial lung disease, creating a significant diagnostic pitfall.
Case Report (n=1)
Biopsy-first strategy mandatory for renal masses with suspicious pulmonary findings to avoid futile surgery; challenges upfront resection without histologic staging.
Introduction: Pulmonary lymphangitic carcinomatosis (PLC) is a rare manifestation of renal cell carcinoma (RCC) that can mimic benign interstitial lung disease, creating a significant diagnostic pitfall. This case report highlights how such a misinterpretation led to inappropriate surgical management and underscores the importance of a biopsy-first approach in suspected metastatic RCC. This report follows the SCARE 2025 Checklist. Case presentation: A 53-year-old woman presented with respiratory symptoms, a left renal mass, and pulmonary interstitial changes initially misinterpreted as sarcoidosis. Based on this, she underwent a cytoreductive nephrectomy, which revealed clear cell RCC with 10% sarcomatoid differentiation. A subsequent bronchoscopy with PAX8-positive biopsy confirmed the pulmonary findings were PLC. Despite treatment with sunitinib and later pembrolizumab plus axitinib, the disease progressed rapidly, and she died 14 months after diagnosis. Clinical discussion: This case demonstrates a critical diagnostic challenge where PLC mimicked sarcoidosis. The decision to perform nephrectomy before obtaining a definitive histological diagnosis from the lungs represents a deviation from the standard of care. In cases of widespread, aggressive disease with poor-prognosis features like sarcomatoid differentiation, the benefit of upfront cytoreductive surgery is minimal, and management should prioritize systemic therapy. Conclusion: In patients, with a renal mass and suspicious pulmonary findings, a definitive histological diagnosis from the suspected metastatic site is mandatory before considering major surgery. This case strongly advocates for a biopsy-first strategy to ensure appropriate staging, guide timely systemic or palliative therapy, and avoid the morbidity of futile surgery.
No takes yet. Share an insight, caveat, or question.
Debiche et al. (2026) conducted a case report in Renal cell carcinoma with pulmonary lymphangitic carcinomatosis (n=1). Cytoreductive nephrectomy, sunitinib, pembrolizumab, and axitinib was evaluated. Misinterpreting pulmonary lymphangitic carcinomatosis as sarcoidosis in a 53-year-old woman with renal cell carcinoma led to inappropriate nephrectomy and death 14 months after diagnosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: